...
首页> 外文期刊>Basic Research in Cardiology: Official Journal of the German Association of Cardiovascular Research >The role of p38 mitogen-activated protein kinase in myocardial ischemia/reperfusion injury; relationship to ischemic preconditioning.
【24h】

The role of p38 mitogen-activated protein kinase in myocardial ischemia/reperfusion injury; relationship to ischemic preconditioning.

机译:p38丝裂原活化蛋白激酶在心肌缺血/再灌注损伤中的作用;与缺血预处理的关系。

获取原文
获取原文并翻译 | 示例
           

摘要

Myocardial mitogen-activated protein kinases can be activated by ischemia and reperfusion, and they may play important roles in the evolution of ischemic injury. Considerable work has been performed to evaluate the role of different MAPK signaling pathways in ischemia/reperfusion injury. The focus of this review is the p38 MAPK pathway, specifically whether activation of the p38 MAPK signaling pathway is beneficial or detrimental. Different studies have come to conflicting conclusions. This review will examine the literature on the role of p38 MAPK in myocardial ischemia/reperfusion injury, highlight areas of controversy and areas of general agreement, examine possible downstream targets of p38 during acute ischemia, and attempt to draw some conclusions.
机译:心肌有丝分裂原激活的蛋白激酶可以被缺血和再灌注激活,它们可能在缺血性损伤的发展中起重要作用。已经进行了大量工作来评估不同的MAPK信号通路在缺血/再灌注损伤中的作用。这篇综述的重点是p38 MAPK途径,特别是激活p38 MAPK信号途径是有益还是有害。不同的研究得出了相互矛盾的结论。这篇综述将研究有关p38 MAPK在心肌缺血/再灌注损伤中的作用的文献,重点讨论有争议的领域和普遍一致的领域,研究急性缺血期间p38可能的下游靶点,并尝试得出一些结论。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号